AMFI - Registered Mutual Fund Distributor

Curis Lifesciences Limited IPO

Curis Lifesciences Limited IPO

₹ 256000 / 2000 Shares Shares
Minimum Investment

Curis Lifesciences Limited IPO

Issues Price

₹120-128 per equity share

Curis Lifesciences Limited IPO

Open Date

07 Nov 2025

Close Date

11 Nov 2025

Lot Size

1000

Min. Investment

₹ 256000

Issue Price

₹120-128

Listing Date

14 Nov 2025

Issues Size

21,50,000 shares(aggregating up to ₹27.52 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

2000 Shares

Offered To Public

2000 Shares

Curis Lifesciences Limited IPO

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.

Founded In

2020

Managing Director

Dharmesh Dasharathbhai Patel

Parent Organization

Curis Lifesciences Limited IPO

Application for Curis Lifesciences Limited IPO

Apply as Price Range Apply Upto
Individual (min) ₹120-128 ₹2,56,000
Individual(max) ₹120-128 ₹2,56,000
SHNI(min) ₹120-128 ₹3,84,000
SHNI(max) ₹120-128 ₹8,96,000
BHNI(min) ₹120-128 ₹10,24,000

Apply for all eligible candidates, Curis Lifesciences Limited IPO.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.7 Out of 5 (3619 Reviews)

KSquare stands out with their personalized approach to NRI investing. Their team’s insights and professionalism are unmatched.

Neel Sharma

Neel Sharma

Real Estate Analyst

KSquare’s NRI Corner was a game-changer for managing my Indian assets. Their process is smooth, transparent, and perfectly suited for NRIs like me.

Pooja Ramesh

Pooja Ramesh

Research Scientist

The pension solutions offered by KSquare are well-structured. I got real-time assistance and no sales pressure at all.

Saurabh Pratap

Saurabh Pratap

Creative Director

I didn’t want to disturb my investments, and KSquare gave me the perfect option. I got the loan in no time.

Nikhil Rane

Nikhil Rane

Visual Designer

I had doubts about NPS before. KSquare explained every detail, making my decision easy. Their support and transparency are unmatched.

Sneha Tiwari

Sneha Tiwari

Financial Analyst

KSquare helped me take my first investment step confidently. I love how easy and flexible their SIP plans are, and the customer care is fantastic.

Simran Kaur

Simran Kaur

Content Writer

Investing used to feel complicated, but KSquare’s SIP process made it simple and stress-free. Now I save monthly without thinking twice.

Shruti Verma

Shruti Verma

Clinical Psychologist

Starting my SIP journey with KSquare was the best decision. Their platform is intuitive, and I feel secure knowing my money is growing steadily.

Tanya Arora

Tanya Arora

Teacher

KSquare offered everything I needed to invest from the UK. Their NRI Corner is efficient, clear, and built with trust.

Rhea Menon

Rhea Menon

Fashion Designer

I never explored NFOs until KSquare simplified the process. Their breakdown of fund objectives helped me make confident decisions as a first-time investor.

Meera Sood

Meera Sood

Interior Decorator

FAQ's

Frequenlty Asked Question

What is the ideal duration for a SIP investment?

The longer the duration, the better the returns. Ideally, stay invested for at least 5–10 years for best results.

What is the difference between SIP and lump sum in mutual funds?

SIP involves regular, small investments over time, while lump sum is a one-time larger investment. SIP is better for market averaging.

What is the minimum amount to start investing with KSquare?

NRIs can begin with as little as ₹1,000 per month depending on the investment vehicle, offering flexible entry points.

What happens if I stop my SIP before maturity?

You can withdraw your invested amount anytime. However, early exits might impact your long-term growth potential.

Can I use LAMF for personal or business purposes?

Yes, the loan can be used for any legal personal or business need such as emergencies, education, or working capital.

Can I invest in mutual funds online through KSquare?

Yes, KSquare’s digital platform allows you to browse, select, and invest in mutual funds entirely online.

Are NFOs better suited for long-term investors?

NFOs are ideal for long-term investors who can wait for the fund to build performance and portfolio over time.

How does KSquare help in retirement planning?

KSquare builds long-term SIP strategies to create a secure retirement corpus based on future lifestyle, needs, and inflation.

App Store